91制片厂

Published on Market Research Reports庐 Inc. ()

Home > Global In Vitro Antibody Production Service Market Growth (Status and Outlook) 2024-2030

Global In Vitro Antibody Production Service Market Growth (Status and Outlook) 2024-2030

Publication ID: 
LPI11241325
Publication Date: 
November 5, 2024
Pages: 
117
Publisher: 
LPI
Countries: 
Global [1]
USD 3,660.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

IT Services [2]
Software [3]
Computing & Electronics [4]
Description: 

In vitro antibody production service refers to a laboratory service that specializes in the production of antibodies using cultured cells. This service typically involves the immunization of animals (like mice or rabbits) to generate a specific immune response, followed by the fusion of immune cells with myeloma cells to create hybridomas. The resulting hybridomas can be cultured in vitro to produce monoclonal antibodies that are specific to a particular antigen. This service is vital for research and diagnostic applications, providing high-quality antibodies for various uses, including immunoassays, therapeutic developments, and scientific investigations. Quality control measures are often implemented to ensure the specificity and functionality of the produced antibodies.
The global In Vitro Antibody Production Service market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淚n Vitro Antibody Production Service Industry Forecast鈥� looks at past sales and reviews total world In Vitro Antibody Production Service sales in 2022, providing a comprehensive analysis by region and market sector of projected In Vitro Antibody Production Service sales for 2023 through 2029. With In Vitro Antibody Production Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world In Vitro Antibody Production Service industry.
This Insight Report provides a comprehensive analysis of the global In Vitro Antibody Production Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on In Vitro Antibody Production Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global In Vitro Antibody Production Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for In Vitro Antibody Production Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global In Vitro Antibody Production Service.
United States market for In Vitro Antibody Production Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for In Vitro Antibody Production Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for In Vitro Antibody Production Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key In Vitro Antibody Production Service players cover Inotiv, GenScript, ProMab Biotechnologies, Bio-Rad, Prosci-Services, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of In Vitro Antibody Production Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
In Vitro Polyclonal Antibody Production Service
In Vitro Monoclonal Antibody Production Service
Segmentation by Application:
University
Research Institute
Pharmaceutical Company
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
In Vitro Polyclonal Antibody Production Service
In Vitro Monoclonal Antibody Production Service
Segmentation by Application:
University
Research Institute
Pharmaceutical Company
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Inotiv
GenScript
ProMab Biotechnologies
Bio-Rad
Prosci-Services
Eurogentec
QED Bio
Creative Biolab
Bio X Cell
BBI Solutions
CUSABIO
Merck

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global In Vitro Antibody Production Service Market Size 2019-2030
2.1.2 In Vitro Antibody Production Service Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for In Vitro Antibody Production Service by Country/Region, 2019, 2023 & 2030
2.2 In Vitro Antibody Production Service Segment by Type
2.2.1 In Vitro Polyclonal Antibody Production Service
2.2.2 In Vitro Monoclonal Antibody Production Service
2.3 In Vitro Antibody Production Service Market Size by Type
2.3.1 In Vitro Antibody Production Service Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global In Vitro Antibody Production Service Market Size Market Share by Type (2019-2024)
2.4 In Vitro Antibody Production Service Segment by Application
2.4.1 University
2.4.2 Research Institute
2.4.3 Pharmaceutical Company
2.4.4 Others
2.5 In Vitro Antibody Production Service Market Size by Application
2.5.1 In Vitro Antibody Production Service Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global In Vitro Antibody Production Service Market Size Market Share by Application (2019-2024)
3 In Vitro Antibody Production Service Market Size by Player
3.1 In Vitro Antibody Production Service Market Size Market Share by Player
3.1.1 Global In Vitro Antibody Production Service Revenue by Player (2019-2024)
3.1.2 Global In Vitro Antibody Production Service Revenue Market Share by Player (2019-2024)
3.2 Global In Vitro Antibody Production Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 In Vitro Antibody Production Service by Region
4.1 In Vitro Antibody Production Service Market Size by Region (2019-2024)
4.2 Global In Vitro Antibody Production Service Annual Revenue by Country/Region (2019-2024)
4.3 Americas In Vitro Antibody Production Service Market Size Growth (2019-2024)
4.4 APAC In Vitro Antibody Production Service Market Size Growth (2019-2024)
4.5 Europe In Vitro Antibody Production Service Market Size Growth (2019-2024)
4.6 Middle East & Africa In Vitro Antibody Production Service Market Size Growth (2019-2024)
5 Americas
5.1 Americas In Vitro Antibody Production Service Market Size by Country (2019-2024)
5.2 Americas In Vitro Antibody Production Service Market Size by Type (2019-2024)
5.3 Americas In Vitro Antibody Production Service Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC In Vitro Antibody Production Service Market Size by Region (2019-2024)
6.2 APAC In Vitro Antibody Production Service Market Size by Type (2019-2024)
6.3 APAC In Vitro Antibody Production Service Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe In Vitro Antibody Production Service Market Size by Country (2019-2024)
7.2 Europe In Vitro Antibody Production Service Market Size by Type (2019-2024)
7.3 Europe In Vitro Antibody Production Service Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa In Vitro Antibody Production Service by Region (2019-2024)
8.2 Middle East & Africa In Vitro Antibody Production Service Market Size by Type (2019-2024)
8.3 Middle East & Africa In Vitro Antibody Production Service Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global In Vitro Antibody Production Service Market Forecast
10.1 Global In Vitro Antibody Production Service Forecast by Region (2025-2030)
10.1.1 Global In Vitro Antibody Production Service Forecast by Region (2025-2030)
10.1.2 Americas In Vitro Antibody Production Service Forecast
10.1.3 APAC In Vitro Antibody Production Service Forecast
10.1.4 Europe In Vitro Antibody Production Service Forecast
10.1.5 Middle East & Africa In Vitro Antibody Production Service Forecast
10.2 Americas In Vitro Antibody Production Service Forecast by Country (2025-2030)
10.2.1 United States Market In Vitro Antibody Production Service Forecast
10.2.2 Canada Market In Vitro Antibody Production Service Forecast
10.2.3 Mexico Market In Vitro Antibody Production Service Forecast
10.2.4 Brazil Market In Vitro Antibody Production Service Forecast
10.3 APAC In Vitro Antibody Production Service Forecast by Region (2025-2030)
10.3.1 China In Vitro Antibody Production Service Market Forecast
10.3.2 Japan Market In Vitro Antibody Production Service Forecast
10.3.3 Korea Market In Vitro Antibody Production Service Forecast
10.3.4 Southeast Asia Market In Vitro Antibody Production Service Forecast
10.3.5 India Market In Vitro Antibody Production Service Forecast
10.3.6 Australia Market In Vitro Antibody Production Service Forecast
10.4 Europe In Vitro Antibody Production Service Forecast by Country (2025-2030)
10.4.1 Germany Market In Vitro Antibody Production Service Forecast
10.4.2 France Market In Vitro Antibody Production Service Forecast
10.4.3 UK Market In Vitro Antibody Production Service Forecast
10.4.4 Italy Market In Vitro Antibody Production Service Forecast
10.4.5 Russia Market In Vitro Antibody Production Service Forecast
10.5 Middle East & Africa In Vitro Antibody Production Service Forecast by Region (2025-2030)
10.5.1 Egypt Market In Vitro Antibody Production Service Forecast
10.5.2 South Africa Market In Vitro Antibody Production Service Forecast
10.5.3 Israel Market In Vitro Antibody Production Service Forecast
10.5.4 Turkey Market In Vitro Antibody Production Service Forecast
10.6 Global In Vitro Antibody Production Service Forecast by Type (2025-2030)
10.7 Global In Vitro Antibody Production Service Forecast by Application (2025-2030)
10.7.1 GCC Countries Market In Vitro Antibody Production Service Forecast
11 Key Players Analysis
11.1 Inotiv
11.1.1 Inotiv Company Information
11.1.2 Inotiv In Vitro Antibody Production Service Product Offered
11.1.3 Inotiv In Vitro Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Inotiv Main Business Overview
11.1.5 Inotiv Latest Developments
11.2 GenScript
11.2.1 GenScript Company Information
11.2.2 GenScript In Vitro Antibody Production Service Product Offered
11.2.3 GenScript In Vitro Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 GenScript Main Business Overview
11.2.5 GenScript Latest Developments
11.3 ProMab Biotechnologies
11.3.1 ProMab Biotechnologies Company Information
11.3.2 ProMab Biotechnologies In Vitro Antibody Production Service Product Offered
11.3.3 ProMab Biotechnologies In Vitro Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 ProMab Biotechnologies Main Business Overview
11.3.5 ProMab Biotechnologies Latest Developments
11.4 Bio-Rad
11.4.1 Bio-Rad Company Information
11.4.2 Bio-Rad In Vitro Antibody Production Service Product Offered
11.4.3 Bio-Rad In Vitro Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Bio-Rad Main Business Overview
11.4.5 Bio-Rad Latest Developments
11.5 Prosci-Services
11.5.1 Prosci-Services Company Information
11.5.2 Prosci-Services In Vitro Antibody Production Service Product Offered
11.5.3 Prosci-Services In Vitro Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Prosci-Services Main Business Overview
11.5.5 Prosci-Services Latest Developments
11.6 Eurogentec
11.6.1 Eurogentec Company Information
11.6.2 Eurogentec In Vitro Antibody Production Service Product Offered
11.6.3 Eurogentec In Vitro Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Eurogentec Main Business Overview
11.6.5 Eurogentec Latest Developments
11.7 QED Bio
11.7.1 QED Bio Company Information
11.7.2 QED Bio In Vitro Antibody Production Service Product Offered
11.7.3 QED Bio In Vitro Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 QED Bio Main Business Overview
11.7.5 QED Bio Latest Developments
11.8 Creative Biolab
11.8.1 Creative Biolab Company Information
11.8.2 Creative Biolab In Vitro Antibody Production Service Product Offered
11.8.3 Creative Biolab In Vitro Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Creative Biolab Main Business Overview
11.8.5 Creative Biolab Latest Developments
11.9 Bio X Cell
11.9.1 Bio X Cell Company Information
11.9.2 Bio X Cell In Vitro Antibody Production Service Product Offered
11.9.3 Bio X Cell In Vitro Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Bio X Cell Main Business Overview
11.9.5 Bio X Cell Latest Developments
11.10 BBI Solutions
11.10.1 BBI Solutions Company Information
11.10.2 BBI Solutions In Vitro Antibody Production Service Product Offered
11.10.3 BBI Solutions In Vitro Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 BBI Solutions Main Business Overview
11.10.5 BBI Solutions Latest Developments
11.11 CUSABIO
11.11.1 CUSABIO Company Information
11.11.2 CUSABIO In Vitro Antibody Production Service Product Offered
11.11.3 CUSABIO In Vitro Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 CUSABIO Main Business Overview
11.11.5 CUSABIO Latest Developments
11.12 Merck
11.12.1 Merck Company Information
11.12.2 Merck In Vitro Antibody Production Service Product Offered
11.12.3 Merck In Vitro Antibody Production Service Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Merck Main Business Overview
11.12.5 Merck Latest Developments
12 Research Findings and Conclusion

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/lpi/global-vitro-antibody-production-service-market-growth-status-and-outlook-2024-2030

Links
[1] /countries/global[2] /it-services[3] /software[4] /computing-electronics